Physician

Yohannes Abraham Gebreegziabher, M.D.

According to 2025 Medicare claims, Yohannes Gebreegziabher, M.D. (NPI: 1700032216) practices cardiology in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is CENTRAL VALLEY CARDIOVASCULAR MEDICAL GROUP, INC (NPI: 1962750224; TIN: 010961637) and primary practice location at 95340-1346. Gebreegziabher is affiliated with the Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), participating under the MSSP model.

Gebreegziabher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,047 traditional Medicare patients, billed 4,233 HCPCS/CPT codes, and received $280,737 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,025 prescription claims across 548 beneficiaries totaling $541,128 in drug costs, led by Eliquis (Apixaban). DME data shows 212 claims. Open Payments data shows 19 records totaling $347. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $117,559 to $541,128. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $16,341 and ending at $8,526.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,383	7,486	$464,440
2016	1,329	6,064	$421,501
2017	1,391	5,935	$406,794
2018	1,424	5,964	$394,239
2019	1,520	6,408	$432,901
2020	1,396	5,281	$338,484
2021	1,206	4,829	$355,169
2022	1,162	4,975	$342,028
2023	1,093	4,968	$349,875
2024	1,047	4,233	$280,737

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	366	2,730	$117,559
2016	403	2,920	$138,135
2017	425	3,515	$290,495
2018	483	3,828	$592,408
2019	543	3,998	$636,329
2020	519	4,133	$689,773
2021	536	4,150	$423,193
2022	509	3,747	$467,998
2023	549	4,102	$536,655
2024	548	4,025	$541,128

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	101	180	$14,191
2016	93	177	$6,831
2017	88	198	$4,715
2018	132	307	$6,893
2019	195	365	$10,227
2020	196	490	$18,021
2021	183	435	$14,747
2022	110	305	$10,569
2023	69	247	$10,012
2024	88	212	$6,989

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	336	443	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	551	1,062	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	264	344	$66
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	487	518	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	352	447	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	281	11,109	$216,671
Xarelto	Rivaroxaban	116	6,656	$123,395
Entresto	Sacubitril/Valsartan	82	3,360	$69,118
Farxiga	Dapagliflozin Propanediol	39	1,530	$26,240
Repatha Sureclick	Evolocumab	19	1,260	$23,309

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	15	29	$2,209
A7031	Face mask interface, replacement for full face mask, each	N	13	27	$2,149
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	32	$926
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	14	$526
A7038	Filter, disposable, used with positive airway pressure device	N	20	38	$382

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$347	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yohannes Abraham Gebreegziabher, M.D.?

Tedicare shows public-source Medicare data for Yohannes Abraham Gebreegziabher, M.D. (NPI 1700032216), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yohannes Abraham Gebreegziabher, M.D. have ACO affiliation data?

Yohannes Abraham Gebreegziabher, M.D. is shown with ACO affiliation data for Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542).

What billing organization is linked to Yohannes Abraham Gebreegziabher, M.D.?

Yohannes Abraham Gebreegziabher, M.D. is linked to CENTRAL VALLEY CARDIOVASCULAR MEDICAL GROUP, INC (billing NPI 1962750224) in the available physician profile data.

Does Yohannes Abraham Gebreegziabher, M.D. have Open Payments data?

Yohannes Abraham Gebreegziabher, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.